Clinical Relevance of Serum Kyn/Trp Ratio and Basal and IFNγ-Upregulated IDO1 Expression in Peripheral Monocytes in Early Stage Melanoma.

MLA

Meireson, Annabel, et al. “Clinical Relevance of Serum Kyn/Trp Ratio and Basal and IFNγ-Upregulated IDO1 Expression in Peripheral Monocytes in Early Stage Melanoma.” Frontiers in Immunology, vol. 12, Sept. 2021, p. 736498. EBSCOhost, https://doi.org/10.3389/fimmu.2021.736498.

APA

Meireson, A., Ferdinande, L., Haspeslagh, M., Hennart, B., Allorge, D., Ost, P., Sundahl, N., Spaas, M., Demeyer, A., & Brochez, L. (2021). Clinical Relevance of Serum Kyn/Trp Ratio and Basal and IFNγ-Upregulated IDO1 Expression in Peripheral Monocytes in Early Stage Melanoma. Frontiers in Immunology, 12, 736498. https://doi.org/10.3389/fimmu.2021.736498

Chicago

Meireson, Annabel, Liesbeth Ferdinande, Marc Haspeslagh, Benjamin Hennart, Delphine Allorge, Piet Ost, Nora Sundahl, Mathieu Spaas, Annelies Demeyer, and Lieve Brochez. 2021. “Clinical Relevance of Serum Kyn/Trp Ratio and Basal and IFNγ-Upregulated IDO1 Expression in Peripheral Monocytes in Early Stage Melanoma.” Frontiers in Immunology 12 (September): 736498. doi:10.3389/fimmu.2021.736498.